Biogen Idec Inc. (Public, NASDAQ:BIIB) In earnings news, Biogen Idec (NASDAQ:BIIB) announced third-quarter net profit of $156.6 million, or 45 cents per share, from $27.2 million, or eight cents per share, in the prior year. Excluding items, earnings surged 67 percent to 60 cents per share, or well above the consensus analysts' view of 49 cents per share. Total revenue at the biotech firm climbed 18 percent to $703.5 million. Looking forward, the company now expects full-year earnings per share of more than $2.20, outpacing Wall Street's current per-share view of $2.09. The stock has rocketed nearly six percent higher in the first few minutes of trading.
http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://www.azhttp.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
